ABMD Abiomed Inc

Price (delayed)

$299.19

Market cap

$13.55B

P/E Ratio

59.84

Dividend/share

N/A

EPS

$5

Enterprise value

$13.32B

Abiomed is a publicly-traded medical devices company that develops and manufactures the circulatory support device Impella, the world’s smallest heart pump. The company is headquartered in Danvers, Massachusetts and has ...

Highlights
ABMD's quick ratio is up by 32% year-on-year and by 10% since the previous quarter
Abiomed's equity has increased by 25% YoY and by 5% from the previous quarter

Key stats

What are the main financial stats of ABMD
Market
Shares outstanding
45.3M
Market cap
$13.55B
Enterprise value
$13.32B
Valuations
Price to earnings (P/E)
59.84
Price to book (P/B)
10.18
Price to sales (P/S)
15.94
EV/EBIT
46.21
EV/EBITDA
42.65
EV/Sales
15.72
Earnings
Revenue
$847.52M
EBIT
$288.22M
EBITDA
$312.32M
Free cash flow
$221.2M
Per share
EPS
$5
Free cash flow per share
$4.9
Book value per share
$29.4
Revenue per share
$18.78
TBVPS
$30.43
Balance sheet
Total assets
$1.49B
Total liabilities
$164.68M
Debt
$0
Equity
$1.33B
Working capital
$659M
Liquidity
Debt to equity
0
Current ratio
6.11
Quick ratio
5.28
Net debt/EBITDA
-0.75
Margins
EBITDA margin
36.9%
Gross margin
80.9%
Net margin
26.6%
Operating margin
27.1%
Efficiency
Return on assets
16.4%
Return on equity
18.5%
Return on invested capital
30.3%
Return on capital employed
21.1%
Return on sales
34%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

ABMD stock price

How has the Abiomed stock price performed over time
Intraday
0.36%
1 week
3.34%
1 month
6.74%
1 year
26.99%
YTD
-7.71%
QTD
-6.13%

Financial performance

How have Abiomed's revenue and profit performed over time
Revenue
$847.52M
Gross profit
$685.62M
Operating income
$229.56M
Net income
$225.53M
Gross margin
80.9%
Net margin
26.6%
The net income has grown by 12% from the previous quarter and by 11% YoY
ABMD's net margin is up by 10% year-on-year and by 8% since the previous quarter
Abiomed's operating margin has decreased by 8% YoY and by 2.2% QoQ
The company's operating income fell by 8% YoY but it rose by 2.1% QoQ

Growth

What is Abiomed's growth rate over time

Valuation

What is Abiomed stock price valuation
P/E
59.84
P/B
10.18
P/S
15.94
EV/EBIT
46.21
EV/EBITDA
42.65
EV/Sales
15.72
ABMD's P/E is 23% below its 5-year quarterly average of 77.4 and 10% below its last 4 quarters average of 66.5
ABMD's EPS is up by 13% since the previous quarter and by 11% year-on-year
Abiomed's equity has increased by 25% YoY and by 5% from the previous quarter
ABMD's P/B is 22% below its 5-year quarterly average of 13.1 and 4.9% below its last 4 quarters average of 10.7
The company's revenue rose by 4.3% QoQ

Efficiency

How efficient is Abiomed business performance
ABMD's return on sales is up by 11% year-on-year and by 9% since the previous quarter
The ROIC has grown by 9% from the previous quarter and by 2.7% YoY
ABMD's return on equity is down by 7% year-on-year but it is up by 6% since the previous quarter
Abiomed's ROA has increased by 6% from the previous quarter but it has decreased by 6% YoY

Dividends

What is ABMD's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for ABMD.

Financial health

How did Abiomed financials performed over time
ABMD's quick ratio is up by 32% year-on-year and by 10% since the previous quarter
Abiomed's current ratio has increased by 27% YoY and by 6% from the previous quarter
ABMD's debt is 100% smaller than its equity
Abiomed's equity has increased by 25% YoY and by 5% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.